Myrtelle Announces Positive 6-month Post-Treatment Data in Patients in Its First-in-Human Clinical Study of rAAV-Olig001-ASPA Gene Therapy in Canavan Disease
Analyses at 6 months showed increases in myelin, white matter and other MRI and MRS measurements as well as functional improvements on validated assessment scales Encouraging initial efficacy data…
Article Date
April 20, 2023
This article is featured on another website.
Go to article
April 30, 2026
Irish Infant Among First to Receive Experimental Gene Therapy
April 30, 2026
Irish Infant Among First to Receive Experimental Gene Therapy
June 1, 2026
HiRO to Attend BIO International Convention 2026 in San Diego
HiRO Is Heading to BIO International Convention 2026 in San Diego, find us a booth…
June 1, 2026
HiRO to Attend BIO International Convention 2026 in San Diego
HiRO Is Heading to BIO International Convention 2026 in San Diego, find us a booth…